Delta-Fly Pharma (TSE:4598) Loans Receivable: 円0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4598 Delta-Fly Pharma Inc TSE:4598
31 GF Score
Price 円106.00
! 2 Warning Signs
View Full Analysis

What is Delta-Fly Pharma Loans Receivable?

Delta-Fly Pharma TSE:4598 +0.95% 31 Loans Receivable is 円0.00 Mil as of Mar. 2026. GuruFocus rates TSE:4598 with a GF Score™ of 31/100. The stock has 2 warning signs investors should review.

Delta-Fly Pharma's Loans Receivable for the quarter that ended in Mar. 2026 was 円0.00 Mil.

Delta-Fly Pharma Loans Receivable Related Terms

Delta-Fly Pharma Loans Receivable Historical Data

* Premium members only.

The historical data trend for Delta-Fly Pharma's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delta-Fly Pharma Loans Receivable Chart

Delta-Fly Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Delta-Fly Pharma Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4598
31GF Score
Delta-Fly Pharma Inc TSE:4598
Loans Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Delta-Fly Pharma Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.

Frequently Asked Questions Learn more about Loans Receivable →
What does a Loans Receivable of 円0.00 Mil mean?
Delta-Fly Pharma (TSE:4598) has a Loans Receivable of 円0.00 Mil as of Mar. 2026. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Delta-Fly Pharma and its competitors.
Is Delta-Fly Pharma's Loans Receivable too high?
Delta-Fly Pharma's current Loans Receivable is 円0.00 Mil. Overall, Delta-Fly Pharma has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Delta-Fly Pharma's Loans Receivable compare to VRTX and REGN?
Delta-Fly Pharma's Loans Receivable of 円0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Loans Receivable for a Biotechnology company?
A good Loans Receivable depends on the Biotechnology industry context. However, Loans Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Loans Receivable mean?
A high Loans Receivable can signal that a stock is expensive relative to its fundamentals. Loans Receivable are the funds that a company has lent but have not yet been repaid. View historical data on Delta-Fly Pharma and its competitors. Delta-Fly Pharma's current Loans Receivable is 円0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Delta-Fly Pharma stock overvalued right now?
Delta-Fly Pharma (TSE:4598) has a current Loans Receivable of 円0.00 Mil. The current Loans Receivable is 円0.00 Mil. Delta-Fly Pharma's overall GF Score™ is 31/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Loans Receivable calculated?
Loans Receivable is calculated from a company's financial statements. For Delta-Fly Pharma (TSE:4598), the current Loans Receivable is 円0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delta-Fly Pharma Business Description

Address 37-5, Miyajima Nishikino, Kawauchi-cho, Tokushima, JPN, 771-0116
Delta-Fly Pharma Inc is a Japan-based company mainly engaged in the discovery and development of gentle anti-cancer agents with module technology.
31GF Score

Get the complete analysis for TSE:4598

Loans Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円106.00
Price